Biotech Values

[PSA declining]

I hope you are right. I'm not sure if the Market is smart enough or will be smart enough to recognize MNTA's immense potential under best case scenario. MNTA's potential will only be realized over time, if other ANDA's get turned down.
What determines which ANDA's get complete examination and final word first?
What are the chances that MNTA hears back first from the FDA?

Thanks for the input! Learned much from reading this board.